Tirzepatide (Mounjaro) is a once-weekly GLP-1/GIP medication that may help eligible patients manage appetite, support weight loss, and improve long-term weight management under medical supervision
Marassi M, Cignarella A, Russo GT, Nollino L, Strazzabosco M, Marzullo P, et al
The Scientific Advisory Committee on Nutrition (SACN) recommends 30 grams of fibre daily from sources such as vegetables, fruits, whole grains, and pulses
Practical Takeaways for Clinics Managing GLP-1 Programs If your clinic offers semaglutide or tirzepatide, your EHR should be able to support GLP-1 protocol management, not just basic charting
Consequently, it has not been widely adopted as a stand-alone treatment for obesity (Table 1)